We are live on ! Find out more
NAMSW icon

NewAmsterdam Pharma Warrant
NAMSW

11 hedge funds and large institutions have $15.9M invested in NewAmsterdam Pharma Warrant in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital inflows, than outflows

Capital inflows: $1.99M | Capital outflows: $1.84M

0.26% less ownership

Funds ownership: 2.01% → 1.74% (-0.26%)

39% less funds holding

Funds holding: 18 → 11 (-7)

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
11
Holders Change
-7
Holders Change %
-38.89%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
10
Calls
$828K
Puts
–
Net Calls
+$828K
Net Calls Change
+$593K

Top Buyers

Rank Fund Capital Flow
1
GTS Securities
GTS Securities
Florida
+$1.1M
2
Affinity Asset Advisors
Affinity Asset Advisors
New York
+$597K
3
Monashee Investment Management
Monashee Investment Management
Massachusetts
+$284K
4
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
+$9.1K

Top Sellers

Rank Fund Capital Flow
1
EcoR1 Capital
EcoR1 Capital
California
-$745K
2
Ensign Peak Advisors
Ensign Peak Advisors
Utah
-$470K
3
ADAR1 Capital Management
ADAR1 Capital Management
Texas
-$259K
4
Westchester Capital Management (New York)
Westchester Capital Management (New York)
New York
-$97.6K
5
Walleye Capital
Walleye Capital
New York
-$70.9K

NAMSW Hedge Fund Activity: Q1 2024 in Review

11 of the 6,966 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q1 2024, worth a combined $15.9M — up 181% from $5.65M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of NAMSW and 3 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was GTS Securities, opening a new position worth an estimated $1.1M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $745K sold.

  • 11 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q1 2024, down from 18 in Q4 2023.
  • Funds reported $15.9M of NewAmsterdam Pharma Warrant stock for Q1 2024, up 181% quarter-over-quarter.
  • 3 funds opened new NewAmsterdam Pharma Warrant positions in Q1 2024 and 10 closed out, a net change of -7 holders.
  • The largest NewAmsterdam Pharma Warrant buyer in Q1 2024 was GTS Securities, an estimated $1.1M added.
  • The largest NewAmsterdam Pharma Warrant seller in Q1 2024 was EcoR1 Capital, an estimated $745K sold.

Based on aggregated 13F filings for Q1 2024.